199 related articles for article (PubMed ID: 25678503)
1. Thoracic multidisciplinary tumor board routinely impacts therapeutic plans in patients with lung and esophageal cancer: a prospective cohort study.
Schmidt HM; Roberts JM; Bodnar AM; Kunz S; Kirtland SH; Koehler RP; Hubka M; Low DE
Ann Thorac Surg; 2015 May; 99(5):1719-24. PubMed ID: 25678503
[TBL] [Abstract][Full Text] [Related]
2. Causes and consequences of deviation from multidisciplinary care in thoracic oncology.
Osarogiagbon RU; Phelps G; McFarlane J; Bankole O
J Thorac Oncol; 2011 Mar; 6(3):510-6. PubMed ID: 21258245
[TBL] [Abstract][Full Text] [Related]
3. The effect of a multidisciplinary thoracic malignancy conference on the treatment of patients with esophageal cancer.
Freeman RK; Van Woerkom JM; Vyverberg A; Ascioti AJ
Ann Thorac Surg; 2011 Oct; 92(4):1239-42; discussion 1243. PubMed ID: 21867990
[TBL] [Abstract][Full Text] [Related]
4. Physician compliance with multidisciplinary tumor board recommendations for managing gynecological cancers.
Naessens C; Laloze J; Leobon S; Gauthier T; Lacorre A; Monteil J; Venat L; Deluche E
Future Oncol; 2023 Apr; 19(13):897-908. PubMed ID: 37232140
[TBL] [Abstract][Full Text] [Related]
5. Analysis of multidisciplinary lung cancer practice.
Conron M; Phuah S; Steinfort D; Dabscheck E; Wright G; Hart D
Intern Med J; 2007 Jan; 37(1):18-25. PubMed ID: 17199840
[TBL] [Abstract][Full Text] [Related]
6. Trimodality therapy for stage IIIA non-small cell lung cancer: benchmarking multi-disciplinary team decision-making and function.
Dickhoff C; Hartemink KJ; van de Ven PM; van Reij EJ; Senan S; Paul MA; Smit EF; Dahele M
Lung Cancer; 2014 Aug; 85(2):218-23. PubMed ID: 24976333
[TBL] [Abstract][Full Text] [Related]
7. Impact of the lung oncology multidisciplinary team meetings on the management of patients with cancer.
Ung KA; Campbell BA; Duplan D; Ball D; David S
Asia Pac J Clin Oncol; 2016 Jun; 12(2):e298-304. PubMed ID: 24674013
[TBL] [Abstract][Full Text] [Related]
8. Validation of team performance assessment of multidisciplinary tumor boards.
Jalil R; Akhter W; Lamb BW; Taylor C; Harris J; Green JS; Sevdalis N
J Urol; 2014 Sep; 192(3):891-8. PubMed ID: 24631109
[TBL] [Abstract][Full Text] [Related]
9. Impact of a multidisciplinary tumour board meeting for upper-GI malignancies on clinical decision making: a prospective cohort study.
van Hagen P; Spaander MC; van der Gaast A; van Rij CM; Tilanus HW; van Lanschot JJ; Wijnhoven BP;
Int J Clin Oncol; 2013 Apr; 18(2):214-9. PubMed ID: 22193638
[TBL] [Abstract][Full Text] [Related]
10. Implementation of a Molecular Tumor Board: The Impact on Treatment Decisions for 35 Patients Evaluated at Dartmouth-Hitchcock Medical Center.
Tafe LJ; Gorlov IP; de Abreu FB; Lefferts JA; Liu X; Pettus JR; Marotti JD; Bloch KJ; Memoli VA; Suriawinata AA; Dragnev KH; Fadul CE; Schwartz GN; Morgan CR; Holderness BM; Peterson JD; Tsongalis GJ; Miller TW; Chamberlin MD
Oncologist; 2015 Sep; 20(9):1011-8. PubMed ID: 26205736
[TBL] [Abstract][Full Text] [Related]
11. Contribution of FDG-PET/CT to the management of esophageal cancer patients at multidisciplinary tumor board conferences.
Shashi KK; Madan R; Hammer MM; van Hedent S; Byrne SC; Schmidlin EJ; Mamon H; Hatabu H; Enzinger PC; Gerbaudo VH
Eur J Radiol Open; 2020; 7():100291. PubMed ID: 33304940
[TBL] [Abstract][Full Text] [Related]
12. Pre-diagnosis Multidisciplinary Tumor Board and Time to Staging in Lung Cancer: The Case Western MetroHealth Experience.
Thalanayar Muthukrishnan P; Ratnam M; Nguyen MT; Le M; Gunzler D; Bruno D; Infeld M
Cureus; 2020 Jan; 12(1):e6595. PubMed ID: 32064177
[TBL] [Abstract][Full Text] [Related]
13. Improving decision making in multidisciplinary tumor boards: prospective longitudinal evaluation of a multicomponent intervention for 1,421 patients.
Lamb BW; Green JS; Benn J; Brown KF; Vincent CA; Sevdalis N
J Am Coll Surg; 2013 Sep; 217(3):412-20. PubMed ID: 23891067
[TBL] [Abstract][Full Text] [Related]
14. An Internet-Based Collaborative Cancer Conference for Rectal Cancer Influenced Surgeon Treatment Recommendations.
Francescutti V; Amin N; Cadeddu M; Eskicioglu C; Forbes S; Kelly S; Yang I; Tsai S; Coates A; Grubac V; Simunovic M
Ann Surg Oncol; 2015 Jul; 22(7):2143-50. PubMed ID: 25384703
[TBL] [Abstract][Full Text] [Related]
15. Uro-oncology multidisciplinary meetings at an Australian tertiary referral centre--impact on clinical decision-making and implications for patient inclusion.
Rao K; Manya K; Azad A; Lawrentschuk N; Bolton D; Davis ID; Sengupta S
BJU Int; 2014 Nov; 114 Suppl 1():50-4. PubMed ID: 25070295
[TBL] [Abstract][Full Text] [Related]
16. Gastrointestinal tumor board: an evolving experience in Tehran Cancer Institute.
Haddad P; Mir MR; Jamali M; Abdirad A; Alikhasi A; Farhan F; Memari F; Sadighi S; Shahi F
Acta Med Iran; 2013 May; 51(4):270-3. PubMed ID: 23690109
[TBL] [Abstract][Full Text] [Related]
17. The effect of a multidisciplinary thoracic malignancy conference on the treatment of patients with lung cancer.
Freeman RK; Van Woerkom JM; Vyverberg A; Ascioti AJ
Eur J Cardiothorac Surg; 2010 Jul; 38(1):1-5. PubMed ID: 20206544
[TBL] [Abstract][Full Text] [Related]
18. Guideline adherence and implementation of tumor board therapy recommendations for patients with gastrointestinal cancer.
Krause A; Stocker G; Gockel I; Seehofer D; Hoffmeister A; Bläker H; Denecke T; Kluge R; Lordick F; Knödler M
J Cancer Res Clin Oncol; 2023 Mar; 149(3):1231-1240. PubMed ID: 35394231
[TBL] [Abstract][Full Text] [Related]
19. Decision making in a multidisciplinary cancer team: does team discussion result in better quality decisions?
Kee F; Owen T; Leathem R
Med Decis Making; 2004; 24(6):602-13. PubMed ID: 15534341
[TBL] [Abstract][Full Text] [Related]
20. [Function and responsibility of an interdisciplinary tumor center. Need for a "cancer center" for multimodal therapy concepts].
Neubauer A; Wolf M; Engenhart-Cabillic R; Rothmund M
Dtsch Med Wochenschr; 2002 Apr; 127(17):901-6. PubMed ID: 12148343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
